99 related articles for article (PubMed ID: 20919907)
1. Pharmacokinetics of metformin after enteral administration in insulin-resistant ponies.
Tinworth KD; Edwards S; Noble GK; Harris PA; Sillence MN; Hackett LP
Am J Vet Res; 2010 Oct; 71(10):1201-6. PubMed ID: 20919907
[TBL] [Abstract][Full Text] [Related]
2. The effect of metformin on measurements of insulin sensitivity and beta cell response in 18 horses and ponies with insulin resistance.
Durham AE; Rendle DI; Newton JE
Equine Vet J; 2008 Jul; 40(5):493-500. PubMed ID: 18482898
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and bioavailability of metformin in horses.
Hustace JL; Firshman AM; Mata JE
Am J Vet Res; 2009 May; 70(5):665-8. PubMed ID: 19405907
[TBL] [Abstract][Full Text] [Related]
4. HPLC-UV determination of metformin in human plasma for application in pharmacokinetics and bioequivalence studies.
Porta V; Schramm SG; Kano EK; Koono EE; Armando YP; Fukuda K; Serra CH
J Pharm Biomed Anal; 2008 Jan; 46(1):143-7. PubMed ID: 18031967
[TBL] [Abstract][Full Text] [Related]
5. The effect of oral metformin on insulin sensitivity in insulin-resistant ponies.
Tinworth KD; Boston RC; Harris PA; Sillence MN; Raidal SL; Noble GK
Vet J; 2012 Jan; 191(1):79-84. PubMed ID: 21349749
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and dose proportionality of extended-release metformin following administration of 1000, 1500, 2000 and 2500 mg in healthy volunteers.
Cullen E; Liao J; Lukacsko P; Niecestro R; Friedhoff L
Biopharm Drug Dispos; 2004 Sep; 25(6):261-3. PubMed ID: 15334625
[TBL] [Abstract][Full Text] [Related]
7. Effect of pregnancy on the pharmacokinetics of metformin.
Hughes RC; Gardiner SJ; Begg EJ; Zhang M
Diabet Med; 2006 Mar; 23(3):323-6. PubMed ID: 16492218
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy, fasting Korean male volunteers.
Kim BH; Shin KH; Kim J; Lim KS; Kim KP; Kim JR; Cho JY; Shin SG; Jang IJ; Yu KS
Clin Ther; 2009 Nov; 31(11):2755-64. PubMed ID: 20110017
[TBL] [Abstract][Full Text] [Related]
9. Tolerability and pharmacokinetics of metformin and the dipeptidyl peptidase-4 inhibitor sitagliptin when co-administered in patients with type 2 diabetes.
Herman GA; Bergman A; Yi B; Kipnes M;
Curr Med Res Opin; 2006 Oct; 22(10):1939-47. PubMed ID: 17022853
[TBL] [Abstract][Full Text] [Related]
10. A study of the pharmacokinetic interactions of the direct renin inhibitor aliskiren with metformin, pioglitazone and fenofibrate in healthy subjects.
Vaidyanathan S; Maboudian M; Warren V; Yeh CM; Dieterich HA; Howard D; Dole WP
Curr Med Res Opin; 2008 Aug; 24(8):2313-26. PubMed ID: 18786303
[TBL] [Abstract][Full Text] [Related]
11. Effects of swimming on the pharmacokinetics and glucose tolerance of metformin in insulin-resistant rats.
Chien KY; Hsu KF; Lo HI; Pan RN; Kuo CH; Chen FA; Hsu MC
Biopharm Drug Dispos; 2008 Jul; 29(5):300-7. PubMed ID: 18551503
[TBL] [Abstract][Full Text] [Related]
12. Preparation and in vitro/in vivo evaluation of sustained-release metformin hydrochloride pellets.
Hu LD; Liu Y; Tang X; Zhang Q
Eur J Pharm Biopharm; 2006 Oct; 64(2):185-92. PubMed ID: 16797948
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of the antihyperglycemic agent metformin in cats.
Michels GM; Boudinot FD; Ferguson DC; Hoenig M
Am J Vet Res; 1999 Jun; 60(6):738-42. PubMed ID: 10376904
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of empagliflozin, a sodium glucose cotransporter-2 (SGLT2) inhibitor, and metformin following co-administration in healthy volunteers.
Macha S; Dieterich S; Mattheus M; Seman LJ; Broedl UC; Woerle HJ
Int J Clin Pharmacol Ther; 2013 Feb; 51(2):132-40. PubMed ID: 23253948
[TBL] [Abstract][Full Text] [Related]
15. Effect of canagliflozin on the pharmacokinetics of glyburide, metformin, and simvastatin in healthy participants.
Devineni D; Manitpisitkul P; Murphy J; Skee D; Wajs E; Mamidi RN; Tian H; Vandebosch A; Wang SS; Verhaeghe T; Stieltjes H; Usiskin K
Clin Pharmacol Drug Dev; 2015; 4(3):226-36. PubMed ID: 27140803
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the potential for pharmacokinetic and pharmacodynamic interactions between dutogliptin, a novel DPP4 inhibitor, and metformin, in type 2 diabetic patients.
Li J; Klemm K; O'Farrell AM; Guler HP; Cherrington JM; Schwartz S; Boyea T
Curr Med Res Opin; 2010 Aug; 26(8):2003-10. PubMed ID: 20583949
[TBL] [Abstract][Full Text] [Related]
17. Effects of metformin hydrochloride on blood glucose and insulin responses to oral dextrose in horses.
Rendle DI; Rutledge F; Hughes KJ; Heller J; Durham AE
Equine Vet J; 2013 Nov; 45(6):751-4. PubMed ID: 23600690
[TBL] [Abstract][Full Text] [Related]
18. Genetic variants of the organic cation transporter 2 influence the disposition of metformin.
Song IS; Shin HJ; Shim EJ; Jung IS; Kim WY; Shon JH; Shin JG
Clin Pharmacol Ther; 2008 Nov; 84(5):559-62. PubMed ID: 18401339
[TBL] [Abstract][Full Text] [Related]
19. Short-term effects of metformin in type 2 diabetes.
Eriksson A; Attvall S; Bonnier M; Eriksson JW; Rosander B; Karlsson FA
Diabetes Obes Metab; 2007 May; 9(3):330-6. PubMed ID: 17391159
[TBL] [Abstract][Full Text] [Related]
20. Dose-independent pharmacokinetics of metformin in rats: Hepatic and gastrointestinal first-pass effects.
Choi YH; Kim SG; Lee MG
J Pharm Sci; 2006 Nov; 95(11):2543-52. PubMed ID: 16937336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
